✦ LIBER ✦

A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions: Results From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) Trial

✍ Scribed by Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Cheol Whan Lee; Soo-Jin Kang; Seung-Jung Park; Jae-Hwan Lee; Si Wan Choi; In-Whan Seong; Nae-Hee Lee; Yoon Haeng Cho; Won-Yong Shin; Seung-Jin Lee; Se-Whan Lee; Min-Su Hyon; Duk-Won Bang; Young-Jin Choi; Hyun-Sook Kim; Bong-Ki Lee; Keun Lee; Hoon-Ki Park; Chang-Bum Park; Sang-Gon Lee; Min-Kyu Kim; Kyoung-Ha Park; Woo-Jung Park

Book ID: 119270131
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 653 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2010.10.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug-Eluting Stenting Followed by Cilost

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)

✍ Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Drug-Eluting Stenting Followed by Cilost

✍ Lee, Seung Whan (author);Park, Seong Wook (author);Kim, Young Hak (author);Yun, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 483 KB

AS-42: A Randomized Comparison of Triple

AS-42: A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy in Patients at High-Risk of Restenosis after Drug-Eluting Stent Implantation: 2-year Clinical Outcomes of DECLARE-DIABETES and LONG Trials

✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB